<qa>  What is the name of the FDA approved for use in all cancer types?In the United States, the Food and Drug Administration FDA has approved 18F-FDG for use in all cancer types. On January 28, 2005 the Centers for Medicare and Medicaid Services CMS announced that it would reimburse PET imaging studies when performed for almost all previously non-covered oncology indications. All previous PET coverage remained fully in effect, and initial staging of cervical cancer was added without conditions but coverage was expanded conditionally to include all cancers and non-covered indications except breast cancer diagnosis and regional lymph node staging. 